Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06735235 · ClinicalTrials.gov registry record · Phase 1
Salivary Fluoride Clearance
A Phase 1 study of Caries, sponsored by Procter and Gamble.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT06735235 is a Phase 1 study of Caries that has completed, run by Procter and Gamble. The registered enrollment target is 27 participants, below the 56-participant average among 7 other Caries trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06735235, a Phase 1 study of Caries, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-center, four-treatment, four-period crossover study. Over the course of the study, up to thirty qualified subjects will use four (4) study treatment products, one time each according to the randomization. Subjects will brush with 1.25g of the assigned study product at each visit. Subjects will provide saliva samples at baseline and at 2, 6, 12, and 30 minutes post-treatment. The F- concentrations in each saliva sample will be determined by ion chromatography
Conditions Studied
Interventions
- DRUG 0 ppm F
- DRUG 250 ppm F as MFP
- DRUG 1100 ppm as MFP
- DRUG 2800 ppm F as MFP
Study Locations (1)
Ohio
- Oral Health Science Center - Mason
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2021-07-14 |
| Est. Completion | 2021-07-29 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06735235
The ClinicalTrials.gov registry entry for NCT06735235 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 56-participant average among 7 other Caries trials with a reported enrollment target (52% lower). The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Caries appearing as the primary indexed condition, and to 4 interventions - of which 0 ppm F is the first listed.
NCT06735235 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06735235 about?
NCT06735235 is a clinical study titled "Salivary Fluoride Clearance". This is a single-center, four-treatment, four-period crossover study. Over the course of the study, up to thirty qualified subjects will use four (4) study treatment products, one time each according to the randomization. Subjects will brush with 1.25g of the assigned study product at each visit. Su...
What is the current status of trial NCT06735235?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2021-07-14. Estimated completion is 2021-07-29.
What conditions does trial NCT06735235 study?
This clinical trial studies the following conditions: Caries.
What interventions are being tested in trial NCT06735235?
The interventions under investigation include: 0 ppm F (DRUG), 250 ppm F as MFP (DRUG), 1100 ppm as MFP (DRUG), 2800 ppm F as MFP (DRUG).
Who is sponsoring clinical trial NCT06735235?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06735235 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Caries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alveolar Ridge Preservation Following Tooth Extraction.
ACTIVE NOT RECRUITING
-
Using Motivational Interviewing To Reduce Parental Risk-Related Behaviors For Early Childhood Caries
COMPLETED · NA
-
Anti-caries Potential of a Sodium Monofluorophosphate and Calcium Sodium Phosphosilicate Dentifrice
COMPLETED · Phase 2
-
In-situ Evaluation of Anti-caries Technology
COMPLETED
-
The Effect of Silver Diamine Fluoride (SDF) on Bacteria Involved in Root or Cervical Carious Lesions
COMPLETED · Phase 4
-
In Situ Comparison of the Remineralization Potential of Optimized Fluoride Dentifrice With Control Fluoride Dentifrice
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.